# Korro Bio, Inc.: insider transactions

KRRO · Nasdaq · CIK 1703647 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/krro.md) · [Financials](/companies/krro/financials.md) · [Filings](/companies/krro/filings.md) · [Insiders](/companies/krro/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Lynx1 Capital Management LP](/insiders/1910456.md) | 10% owner | Purchase (P) | 25,124 | $11.7454 | $295.1k | [Form 4](/filings/0000902664-26-004286.md) |
| 2026-10-23 | [Lynx1 Capital Management LP](/insiders/1910456.md) | 10% owner | Purchase (P) | 2,510 | $12.1061 | $30.4k | [Form 4](/filings/0000902664-26-004286.md) |
| 2026-10-22 | [Lynx1 Capital Management LP](/insiders/1910456.md) | 10% owner | Purchase (P) | 40,000 | $11.0366 | $441.5k | [Form 4](/filings/0000902664-26-004286.md) |
| 2026-10-22 | [Lynx1 Capital Management LP](/insiders/1910456.md) | 10% owner | Purchase (P) | 12,175 | $9.6764 | $117.8k | [Form 4](/filings/0000902664-26-004286.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:32 ET. No prices; not investment advice.